Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.56
- Piotroski Score 4.00
- Grade Buy
- Symbol (RPTX)
- Company Repare Therapeutics Inc.
- Price $2.79
- Changes Percentage (-6.06%)
- Change -$0.18
- Day Low $2.78
- Day High $3.09
- Year High $8.49
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $15.00
- High Stock Price Target $30.00
- Low Stock Price Target $10.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.10
- Trailing P/E Ratio -3.53
- Forward P/E Ratio -3.53
- P/E Growth -3.53
- Net Income $-93,796,000
Income Statement
Quarterly
Annual
Latest News of RPTX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Repare Therapeutics Inc. (RPTX): A Promising Penny Stock in Canada's Evolving Economic Landscape
Discover the top 10 Canadian penny stocks to invest in, including Repare Therapeutics Inc. (NASDAQ:RPTX). Despite economic challenges in Canada, opportunities exist for selective investments....
By Yahoo! Finance | 2 months ago -
We Think Repare Therapeutics (NASDAQ:RPTX) Needs To Drive Business Growth Carefully
Despite Repare Therapeutics' decent cash runway of 2.8 years, its recent significant increase in cash burn and declining revenue raise concerns. Shareholders should monitor the company's ability to ra...
By Yahoo! Finance | 3 months ago
